ALUMBRIA Trademark

Trademark Overview

On Thursday, November 12, 2020, a trademark application was filed for ALUMBRIA with the United States Patent and Trademark Office. The USPTO has given the ALUMBRIA trademark a serial number of 90315616. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 18, 2022. This trademark is owned by Neos Therapeutics, Inc.. The ALUMBRIA trademark is filed in the Pharmaceutical Products category with the following description:

Prescription pharmaceutical preparations for the treatment of disease and disorders of the central nervous system
alumbria

General Information

Serial Number90315616
Word MarkALUMBRIA
Filing DateThursday, November 12, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 18, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 20, 2021

Trademark Statements

Goods and ServicesPrescription pharmaceutical preparations for the treatment of disease and disorders of the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeos Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEnglewood, CO 80112
Party NameNeos Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEnglewood, CO 80112

Trademark Events

Event DateEvent Description
Monday, April 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 18, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 30, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 30, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 30, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 30, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 14, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 23, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 22, 2021NON-FINAL ACTION E-MAILED
Thursday, April 22, 2021NON-FINAL ACTION WRITTEN
Wednesday, April 21, 2021ASSIGNED TO EXAMINER
Thursday, April 1, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 1, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 1, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 1, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 1, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 1, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, February 24, 2021ASSIGNED TO LIE
Tuesday, January 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 23, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, November 16, 2020NEW APPLICATION ENTERED

Related Keywords

alumbria central nervous system disorders disease pharmaceutical preparations treatment prescription